Functional experiments confirmed that the activation of P4HB by LGALS9 significantly enhanced proliferation, epithelial‐mesenchymal transition (EMT) and lipid metabolism in gastric cancer cells, while pharmacological inhibition of P4HB reversed these effects. This evidence concerns the gene LGALS9 and gastric cancer.